Manufacturers

Newsletter

Glucozid Tablet View full size

Glucozid Tablet

Glucozid

Gliclazide

Gliclazide is a second-generation oral hypoglycemic sulfonylurea, which stimulates the release of insulin from pancreatic beta cells by facilitating Ca++ transport across the beta-cell membrane and decreases hepatic glucose output.

Manufacturer: Aristopharma Ltd

More details

Tk. 350.02

On sale On sale!

Glucozid

Gliclazide

Gliclazide is a second-generation oral hypoglycemic sulfonylurea, which stimulates the release of insulin from pancreatic beta cells by facilitating Ca++ transport across the beta-cell membrane and decreases hepatic glucose output.

Presentation

Glucozid Tablet: Each Glucozid tablet contains Gliclazide BP 80 mg.

Indication

Glucozid (Gliclazide) is indicated for control of blood glucose in patients with non-insulin dependent diabetes mellitus (Type-II, maturity onset diabetes mellitus) whose hyperglycemia cannot be controlled by diet alone.

Dosage & Administration

Initially, 40-80 mg daily adjusted according to response, up to 160 mg as a single dose with breakfast; higher doses divided; Max. 320 mg daily.

Packing

Glucozid Tablet: Each box contains 50's tablets in blister pack.

After saving your customized product, remember to add it to your cart.

Add unit type

* required fields

Write your review

Glucozid Tablet

Glucozid Tablet

Glucozid

Gliclazide

Gliclazide is a second-generation oral hypoglycemic sulfonylurea, which stimulates the release of insulin from pancreatic beta cells by facilitating Ca++ transport across the beta-cell membrane and decreases hepatic glucose output.

Manufacturer: Aristopharma Ltd

Write your review